Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis

  • 📰 ABC
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

One company has agreed to pay New York $523 million to settle claims stemming from its role in the opioids crisis.

It’s the largest settlement New York has reached with an individual opioid defendant and raises the total amount secured from opioid manufacturers and distributors to more than $2 billion to combat the damage the pills have caused.

Teva reached a tentative nationwide settlement of $4.2 billion in July to settle all opioids-related litigation, which is still awaiting approval. New York gets a piece of that plus more from a successful lawsuit against Teva in Suffolk County. New York accused Teva of misrepresenting its products for decades and flooding the market with dangerous prescription drugs. However, the settlement does not require Teva to admit to this practice.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Hopefully we'll get to the point where they have to pay for the vaccine injuries as well.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 471. in BUSİNESS

Business Business Latest News, Business Business Headlines